Glargine and cancer: can we now suggest closure?

Diabetes Care. 2012 Dec;35(12):2426-8. doi: 10.2337/dc12-1968.
No abstract available

Publication types

  • Comment

MeSH terms

  • Diabetes Mellitus, Type 1 / drug therapy*
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Diabetes Mellitus, Type 2 / metabolism*
  • Female
  • Humans
  • Hypoglycemic Agents / administration & dosage*
  • Hypoglycemic Agents / blood*
  • Insulin Glargine
  • Insulin, Long-Acting / administration & dosage*
  • Insulin, Long-Acting / blood*
  • Insulin, Long-Acting / pharmacokinetics*
  • Male

Substances

  • Hypoglycemic Agents
  • Insulin, Long-Acting
  • Insulin Glargine